0001011034-11-000027.txt : 20110316 0001011034-11-000027.hdr.sgml : 20110316 20110316161804 ACCESSION NUMBER: 0001011034-11-000027 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110316 DATE AS OF CHANGE: 20110316 EFFECTIVENESS DATE: 20110316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARROGENE NANOTECHNOLOGY INC CENTRAL INDEX KEY: 0001501627 IRS NUMBER: 273439233 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-147950 FILM NUMBER: 11692061 BUSINESS ADDRESS: STREET 1: 15332 ANTIOCH STREET STREET 2: 303 CITY: PACIFIC PALISADES STATE: CA ZIP: 90272 BUSINESS PHONE: 310-454-9757 MAIL ADDRESS: STREET 1: 15332 ANTIOCH STREET STREET 2: 303 CITY: PACIFIC PALISADES STATE: CA ZIP: 90272 D/A 1 primary_doc.xml X0704 D/A LIVE 0001501627 ARROGENE NANOTECHNOLOGY INC 15332 ANTIOCH STREET 303 PACIFIC PALISADES CA CALIFORNIA 90272 310-454-9757 CALIFORNIA None None Corporation true 2007 Maurizio Vecchione 15332 Antioch Street # 303 Pacific Palisades CA CALIFORNIA 90272 Executive Officer Promoter Julia Ljubimova 15332 Antioch Street # 303 Pacific Palisades CA CALIFORNIA 90272 Executive Officer Director Promoter Alexander Ljubimov 15332 Antioch Street # 303 Pacific Palisades CA CALIFORNIA 90272 Executive Officer Director Promoter Robert Stuckelman 15332 Antioch Street # 303 Pacific Palisades CA CALIFORNIA 90272 Executive Officer Director Promoter Marc Rosenberg 15332 Antioch Street # 303 Pacific Palisades CA CALIFORNIA 90272 Director Promoter Eggehard Holler 15332 Antioch Street # 303 Pacific Palisades CA CALIFORNIA 90272 Executive Officer Director Promoter Biotechnology Decline to Disclose 06 true 0001011034-10-000197 2010-10-12 false true false 0 GVC Capital, LLC 38923 None None 5350 S. Roslyn Street # 400 Greenwood Village CO COLORADO 80111 CO COLORADO MD MARYLAND MI MICHIGAN NJ NEW JERSEY WA WASHINGTON false 600000 496550 103450 false 33 60000 true 0 0 false ARROGENE NANOTECHNOLOGY INC /s/ Jeff Sperber Jeff Sperber CFO 2011-03-15